These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20172362)

  • 1. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.
    Vickers AJ; Cronin AM
    Semin Oncol; 2010 Feb; 37(1):31-8. PubMed ID: 20172362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calibration of risk prediction models: impact on decision-analytic performance.
    Van Calster B; Vickers AJ
    Med Decis Making; 2015 Feb; 35(2):162-9. PubMed ID: 25155798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision curve analysis to evaluate the clinical benefit of prediction models.
    Vickers AJ; Holland F
    Spine J; 2021 Oct; 21(10):1643-1648. PubMed ID: 33676020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards better clinical prediction models: seven steps for development and an ABCD for validation.
    Steyerberg EW; Vergouwe Y
    Eur Heart J; 2014 Aug; 35(29):1925-31. PubMed ID: 24898551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.
    Cook NR
    Clin Chem; 2008 Jan; 54(1):17-23. PubMed ID: 18024533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study.
    Bernal W; Wang Y; Maggs J; Willars C; Sizer E; Auzinger G; Murphy N; Harding D; Elsharkawy A; Simpson K; Larsen FS; Heaton N; O'Grady J; Williams R; Wendon J
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):217-225. PubMed ID: 28404094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models.
    Olchanski N; Cohen JT; Neumann PJ; Wong JB; Kent DM
    Med Decis Making; 2017 Oct; 37(7):790-801. PubMed ID: 28399375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a risk prediction model for Barrett's esophagus in an Australian population.
    Ireland CJ; Fielder AL; Thompson SK; Laws TA; Watson DI; Esterman A
    Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision curve analysis: a novel method for evaluating prediction models.
    Vickers AJ; Elkin EB
    Med Decis Making; 2006; 26(6):565-74. PubMed ID: 17099194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.
    Vickers AJ; Cronin AM; Elkin EB; Gonen M
    BMC Med Inform Decis Mak; 2008 Nov; 8():53. PubMed ID: 19036144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance measures for prediction models and markers: evaluation of predictions and classifications].
    Steyerberg EW; Van Calster B; Pencina MJ
    Rev Esp Cardiol; 2011 Sep; 64(9):788-94. PubMed ID: 21763052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting risk prediction in perspective: relative utility curves.
    Baker SG
    J Natl Cancer Inst; 2009 Nov; 101(22):1538-42. PubMed ID: 19843888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.
    Leening MJ; Vedder MM; Witteman JC; Pencina MJ; Steyerberg EW
    Ann Intern Med; 2014 Jan; 160(2):122-31. PubMed ID: 24592497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random-effects meta-analysis of the clinical utility of tests and prediction models.
    Wynants L; Riley RD; Timmerman D; Van Calster B
    Stat Med; 2018 May; 37(12):2034-2052. PubMed ID: 29575170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.
    Bansal A; Heagerty PJ
    Med Decis Making; 2018 Nov; 38(8):904-916. PubMed ID: 30319014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.